Literature DB >> 10501568

Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder.

L Caberlotto1, Y L Hurd.   

Abstract

In the present study, we compared neuropeptide Y mRNA expression levels in the prefrontal cortex (Brodmann area 9 and 46) of subjects diagnosed with major depression, bipolar disorder and schizophrenia with those in normal controls without a psychiatric history. No correlation was found regarding neuropeptide Y mRNA expression and postmortem interval, age, gender, hemisphere side, suicide as cause of death, or the history of use of substances such as alcohol, marihuana and cocaine/amphetamine. The only significant alteration found was related to the clinical diagnosis; neuropeptide Y mRNA expression was reduced in the group of bipolar subjects as compared to the controls. Overall, the present results confirm an involvement of neuropeptide Y in affective disorders, and show for the first time a specific association between NPY and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501568     DOI: 10.1097/00001756-199906030-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

1.  DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles.

Authors:  S J Evans; P V Choudary; M P Vawter; J Li; J H Meador-Woodruff; J F Lopez; S M Burke; R C Thompson; R M Myers; E G Jones; W E Bunney; S J Watson; H Akil
Journal:  Neurobiol Dis       Date:  2003-11       Impact factor: 5.996

2.  Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.

Authors:  Wolfgang H Sommer; Jessica Lidström; Hui Sun; Derek Passer; Robert Eskay; Stephen C J Parker; Stephanie H Witt; Ulrich S Zimmermann; Vanessa Nieratschker; Marcella Rietschel; Elliott H Margulies; Miklós Palkovits; Manfred Laucht; Markus Heilig
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

3.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

4.  Emotion processing, major depression, and functional genetic variation of neuropeptide Y.

Authors:  Brian J Mickey; Zhifeng Zhou; Mary M Heitzeg; Elizabeth Heinz; Colin A Hodgkinson; David T Hsu; Scott A Langenecker; Tiffany M Love; Marta Peciña; Tal Shafir; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  Arch Gen Psychiatry       Date:  2011-02

Review 5.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

6.  Neuropeptide Y-immunoreactive neurons in the cerebral cortex of humans and other haplorrhine primates.

Authors:  Mary Ann Raghanti; Tiffini Conley; Jessica Sudduth; Joseph M Erwin; Cheryl D Stimpson; Patrick R Hof; Chet C Sherwood
Journal:  Am J Primatol       Date:  2012-10-05       Impact factor: 2.371

7.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 8.  Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.

Authors:  Elizabeth K Nousen; Juliana G Franco; Elinor L Sullivan
Journal:  Neuroendocrinology       Date:  2013-09-21       Impact factor: 4.914

9.  Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways.

Authors:  C Anthony Altar; Pascal Laeng; Linda W Jurata; Jeffrey A Brockman; Andrew Lemire; Jeffrey Bullard; Yury V Bukhman; Theresa A Young; Vinod Charles; Michael G Palfreyman
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

10.  NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder.

Authors:  Harvey M Morris; Rachelle E Stopczynski; David A Lewis
Journal:  Schizophr Res       Date:  2009-10-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.